Plus therapeutics announces comprehensive restructuring of $15 million march 2025 equity financing

Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock plus therapeutics files a request to withdraw the related resale registration statement with the sec
PSTV Ratings Summary
PSTV Quant Ranking